Skip to main content

Table 3 Estimated relative risk (odds ratio) of exhibiting metabolic syndrome components associated with the SST poly-T repeat polymorphism genotype

From: Association study between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and metabolic syndrome

  Genotypes   Abdominal
Obesity 		Hypertriglyceridemia Low HDL-Cholesterol Hypertension Hyperglycaemia Metabolic
Syndrome
Entire samplea 13/13 p=
OR 		1 1 1 1 1 1
13/14 OR 1.46 1.24 0.96 0.66 1.68 1.10
p-value
95%CI 		0.18
(0.84–2.53) 		0.39
(0.76–2.04) 		0.87
(0.59–1.57) 		0.18
(0.36–1.21) 		0.05
(1.01–2.81) 		0.71
(0.66–1.83)
13/15 OR 1.07 1.24 1.02 1.26 1.07 1.13
p-value
95%CI 		0.57
(0.85–1.34) 		0.05
(1.01–1.53) 		0.85
(0.83–1.26) 		0.05
(1.00–1.59) 		0.53
(0.86–1.34) 		0.28
(0.91–1.40)
13/16 OR 1.60 1.55 1.55 1.48 1.43 1.79
p-value
95%CI 		0.01
(1.10–2.33) 		0.01
(1.11–2.17) 		0.01
(1.11–2.17) 		0.03
(1.04–2.11) 		0.04
(1.02–2.02) 		<  0.01
(1.27–2.53)
Menb 13/13 OR 1 1 1 1 1 1
13/14 OR 0.99 1.49 0.79 0.55 1.71 0.85
p-value
95%CI 		0.98
(0.46–2.12) 		0.25
(0.75–2.96) 		0.50
(0.41–1.54) 		0.15
(0.24–1.25) 		0.12
(0.87–3.37) 		0.64
(0.66–1.83)
13/15 OR 0.91 1.32 1.03 1.09 0.99 1.00
p-value
95%CI 		0.58
(0.65–1.27) 		0.07
(0.98–1.78) 		0.84
(0.77–1.39) 		0.59
(0.79–1.50) 		0.96
(0.73–1.34) 		1.00
(0.91–1.40)
13/16 OR 1.43 1.93 1.68 1.08 1.26 1.50
p-value
95%CI 		0.20
(0.83–2.47) 		0.01
(1.22–3.07) 		0.03
(1.06–2.65) 		0.75
(0.68–1.72) 		0.31
(0.81–1.96) 		0.08
(0.95–2.37)
Womenb 13/13 OR 1 1 1 1 1 1
13/14 OR 2.08 1.04 1.21 0.86 1.66 1.59
p-value
95%CI 		0.06
(0.98–4.42) 		0.91
(0.49–2.21) 		0.61
(0.58–2.52) 		0.74
(0.35–2.11) 		0.21
(0.75–3.67) 		0.24
(0.74–3.43)
13/15 OR 1.22 1.12 1.01 1.45 1.17 1.26
p-value
95%CI 		0.21
(0.89–1.66) 		0.49
(0.82–1.52) 		0.94
(0.75–1.37) 		0.03
(1.03–2.04) 		0.35
(0.84–1.64) 		0.16
(0.91–1.73)
13/16 OR 1.77 1.19 1.41 2.33 1.73 2.25
p-value
95%CI 		0.03
(1.06–2.95) 		0.51
(0.72–1.98) 		0.18
(0.86–2.32) 		<  0.01
(1.33–4.09) 		0.04
(1.02–2.93) 		< 0.01
(1.33–3.79)
  1. aIncluding age and sex as covariates
  2. bIncluding age as a covariate
  3. Significant p-values were italicized
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us